REGENERON PHARMACEUTICALS, INC. Other Noncash Income (Expense)
REGENERON PHARMACEUTICALS, INC. (REGN) reported Other Noncash Income (Expense) of -$110.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$54.90M, a 362.68% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$55.60M.
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$136.90M.
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$16.30M, a 156.21% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2025 was -$135.50M.
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2024 was -$36.10M, a 36200.00% decline from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2023 was $100.00K.
- REGENERON PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2022 was -$368.00M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$54.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$110.50M 10-Q · filed 2026-07-30 | -$247.40M derived: sum of 3 quarters · filed 2026-07-30 | -$263.70M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$55.60M 10-Q · filed 2026-04-29 | -$192.50M derived: sum of 2 quarters · filed 2026-04-29 | -$208.80M derived: sum of 3 quarters · filed 2026-04-29 | -$187.90M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$136.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | -$153.20M derived: sum of 2 quarters · filed 2026-02-04 | -$132.30M derived: sum of 3 quarters · filed 2026-07-30 | -$135.50M 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | -$16.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $4.60M derived: sum of 2 quarters · filed 2026-07-30 | $1.40M 10-Q · filed 2025-10-28 | -$66.60M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $20.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $17.70M 10-Q · filed 2026-07-30 | -$50.30M derived: sum of 3 quarters · filed 2026-07-30 | -$21.30M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$3.20M 10-Q · filed 2026-04-29 | -$71.20M derived: sum of 2 quarters · filed 2026-04-29 | -$42.20M derived: sum of 3 quarters · filed 2026-04-29 | -$39.20M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | -$68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | -$39.00M derived: sum of 2 quarters · filed 2026-02-04 | -$36.00M derived: sum of 3 quarters · filed 2026-02-04 | -$36.10M 10-K · filed 2026-02-04 | -$23.50M 10-K · filed 2025-02-05 | |||
| 2024-09-30 | $29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $32.00M derived: sum of 2 quarters · filed 2025-10-28 | $31.90M 10-Q · filed 2025-10-28 | $49.40M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $2.90M 10-Q · filed 2025-08-01 | $20.40M derived: sum of 3 quarters · filed 2026-02-04 | $32.20M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | -$100.00K 10-Q · filed 2025-04-29 | $17.40M derived: sum of 2 quarters · filed 2026-02-04 | $29.20M derived: sum of 3 quarters · filed 2026-02-04 | $20.60M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | $17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $29.30M derived: sum of 2 quarters · filed 2026-02-04 | $20.70M derived: sum of 3 quarters · filed 2026-02-04 | $100.00K 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $11.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $3.20M derived: sum of 2 quarters · filed 2024-10-31 | -$17.40M 10-Q · filed 2024-10-31 | -$186.40M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | -$8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$29.20M 10-Q · filed 2024-08-01 | -$198.20M derived: sum of 3 quarters · filed 2025-02-05 | -$258.90M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | -$20.60M 10-Q · filed 2024-05-02 | -$189.60M derived: sum of 2 quarters · filed 2025-02-05 | -$250.30M derived: sum of 3 quarters · filed 2025-02-05 | -$304.30M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | -$169.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | -$229.70M derived: sum of 2 quarters · filed 2025-02-05 | -$283.70M derived: sum of 3 quarters · filed 2025-02-05 | -$368.00M 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | -$60.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$114.70M derived: sum of 2 quarters · filed 2023-11-02 | -$199.00M 10-Q · filed 2023-11-02 | -$503.30M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | -$54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$138.30M 10-Q · filed 2023-08-03 | -$442.60M derived: sum of 3 quarters · filed 2024-02-05 | -$514.40M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | -$84.30M 10-Q · filed 2023-05-04 | -$388.60M derived: sum of 2 quarters · filed 2024-02-05 | -$460.40M derived: sum of 3 quarters · filed 2024-02-05 | -$624.30M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | -$304.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | -$376.10M derived: sum of 2 quarters · filed 2024-02-05 | -$540.00M derived: sum of 3 quarters · filed 2024-02-05 | -$568.70M 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | -$71.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$235.70M derived: sum of 2 quarters · filed 2022-11-03 | -$264.40M 10-Q · filed 2022-11-03 | -$300.20M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | -$163.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$192.60M 10-Q · filed 2022-08-03 | -$228.40M derived: sum of 3 quarters · filed 2023-02-06 | -$255.60M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | -$28.70M 10-Q · filed 2022-05-04 | $115.70M 10-Q · filed 2021-05-06 | -$64.50M derived: sum of 2 quarters · filed 2023-02-06 | -$91.70M derived: sum of 3 quarters · filed 2023-02-06 | -$32.90M derived: sum of 4 quarters · filed 2023-02-06 | |||
| 2020-12-31 | -$35.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | -$63.00M derived: sum of 2 quarters · filed 2023-02-06 | -$4.20M derived: sum of 3 quarters · filed 2023-02-06 | -$86.80M 10-K · filed 2023-02-06 | $135.00M 10-K · filed 2021-02-08 | |||
| 2020-09-30 | -$27.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $31.60M derived: sum of 2 quarters · filed 2021-11-04 | -$51.00M 10-Q · filed 2021-11-04 | $111.30M 10-Q · filed 2020-11-05 | -$40.00M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2020-06-30 | $58.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$23.80M 10-Q · filed 2021-08-05 | $175.80M 10-Q · filed 2020-08-05 | -$12.80M derived: sum of 3 quarters · filed 2022-02-07 | -$15.30M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2020-03-31 | -$82.60M 10-Q · filed 2021-05-06 | -$71.60M derived: sum of 2 quarters · filed 2022-02-07 | -$74.10M derived: sum of 3 quarters · filed 2022-02-07 | -$208.60M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $8.50M derived: sum of 2 quarters · filed 2022-02-07 | -$126.00M derived: sum of 3 quarters · filed 2022-02-07 | -$102.20M 10-K · filed 2022-02-07 | $29.30M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$137.00M derived: sum of 2 quarters · filed 2020-11-05 | -$113.20M 10-Q · filed 2020-11-05 | -$208.00M derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-06-30 | -$134.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$110.70M 10-Q · filed 2020-08-05 | -$205.50M derived: sum of 3 quarters · filed 2021-02-08 | -$177.70M derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-03-31 | $23.80M 10-Q · filed 2020-05-05 | -$71.00M derived: sum of 2 quarters · filed 2021-02-08 | -$43.20M derived: sum of 3 quarters · filed 2021-02-08 | $7.50M derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2018-12-31 | -$94.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | -$67.00M derived: sum of 2 quarters · filed 2021-02-08 | -$16.30M derived: sum of 3 quarters · filed 2021-02-08 | -$12.10M 10-K · filed 2021-02-08 | ||||
| 2018-09-30 | $27.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $78.50M derived: sum of 2 quarters · filed 2019-11-05 | $82.70M 10-Q · filed 2019-11-05 | $82.69M 10-Q · filed 2018-11-06 | $63.22M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-06-30 | $50.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $54.90M 10-Q · filed 2019-08-06 | $54.98M 10-Q · filed 2018-08-02 | $35.42M derived: sum of 3 quarters · filed 2020-02-07 | $29.03M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-03-31 | $4.20M 10-Q · filed 2019-05-07 | $4.19M 10-Q · filed 2018-05-03 | -$15.28M derived: sum of 2 quarters · filed 2020-02-07 | -$21.67M derived: sum of 3 quarters · filed 2020-02-07 | -$55.34M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | -$19.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | -$25.87M derived: sum of 2 quarters · filed 2020-02-07 | -$59.54M derived: sum of 3 quarters · filed 2020-02-07 | -$63.50M 10-K · filed 2020-02-07 | -$63.58M 10-K · filed 2018-02-08 | |||
| 2017-09-30 | -$6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$40.06M derived: sum of 2 quarters · filed 2018-11-06 | -$44.02M 10-Q · filed 2018-11-06 | -$75.53M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | -$33.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$37.63M 10-Q · filed 2018-08-02 | -$69.14M derived: sum of 3 quarters · filed 2019-02-07 | -$74.94M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | -$3.96M 10-Q · filed 2018-05-03 | -$35.47M derived: sum of 2 quarters · filed 2019-02-07 | -$41.26M derived: sum of 3 quarters · filed 2019-02-07 | -$45.10M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | -$31.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | -$37.30M derived: sum of 2 quarters · filed 2019-02-07 | -$41.14M derived: sum of 3 quarters · filed 2019-02-07 | -$45.10M 10-K · filed 2019-02-07 | -$45.14M 10-K · filed 2017-02-09 | |||
| 2016-09-30 | -$5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$9.63M derived: sum of 2 quarters · filed 2017-11-08 | -$13.59M 10-Q · filed 2017-11-08 | -$31.23M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | -$3.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$7.79M 10-Q · filed 2017-08-03 | -$25.44M derived: sum of 3 quarters · filed 2018-02-08 | -$27.34M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | -$3.96M 10-Q · filed 2017-05-04 | -$21.60M derived: sum of 2 quarters · filed 2018-02-08 | -$23.50M derived: sum of 3 quarters · filed 2018-02-08 | -$47.71M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | -$17.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | -$19.55M derived: sum of 2 quarters · filed 2018-02-08 | -$43.75M derived: sum of 3 quarters · filed 2018-02-08 | -$52.56M 10-K · filed 2018-02-08 | -$33.70M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$26.11M derived: sum of 2 quarters · filed 2016-11-04 | -$34.92M 10-Q · filed 2016-11-04 | -$33.20M 10-Q · filed 2015-11-04 | -$84.02M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2015-06-30 | -$24.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$33.02M 10-Q · filed 2016-08-04 | -$17.63M 10-Q · filed 2015-08-04 | -$82.11M derived: sum of 3 quarters · filed 2017-02-09 | -$103.99M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2015-03-31 | -$8.81M 10-Q · filed 2016-05-05 | -$6.01M 10-Q · filed 2015-05-07 | -$57.91M derived: sum of 2 quarters · filed 2017-02-09 | -$79.78M derived: sum of 3 quarters · filed 2017-02-09 | -$82.62M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2014-12-31 | -$49.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | -$70.97M derived: sum of 2 quarters · filed 2017-02-09 | -$73.81M derived: sum of 3 quarters · filed 2017-02-09 | -$77.57M 10-K · filed 2017-02-09 | -$30.00M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | -$21.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$24.71M derived: sum of 2 quarters · filed 2015-11-04 | -$28.47M 10-Q · filed 2015-11-04 | -$12.84M 10-Q · filed 2014-11-04 | -$59.51M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-06-30 | -$2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$6.60M 10-Q · filed 2015-08-04 | -$37.64M derived: sum of 3 quarters · filed 2016-02-11 | -$35.03M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | -$3.76M 10-Q · filed 2015-05-07 | -$34.80M derived: sum of 2 quarters · filed 2016-02-11 | -$32.19M derived: sum of 3 quarters · filed 2016-02-11 | -$43.34M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | -$31.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$28.43M derived: sum of 2 quarters · filed 2016-02-11 | -$39.58M derived: sum of 3 quarters · filed 2016-02-11 | -$46.75M 10-K · filed 2016-02-11 | -$23.69M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$8.54M derived: sum of 2 quarters · filed 2014-11-04 | -$15.71M 10-Q · filed 2014-11-04 | -$36.12M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | -$11.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$18.32M 10-Q · filed 2014-08-05 | -$38.74M derived: sum of 3 quarters · filed 2015-02-12 | -$41.32M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | -$7.17M 10-Q · filed 2014-05-08 | -$27.59M derived: sum of 2 quarters · filed 2015-02-12 | -$30.17M derived: sum of 3 quarters · filed 2015-02-12 | -$38.73M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | -$20.41M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$22.99M derived: sum of 2 quarters · filed 2015-02-12 | -$31.55M derived: sum of 3 quarters · filed 2015-02-12 | -$34.05M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$11.14M derived: sum of 2 quarters · filed 2013-11-05 | -$13.64M 10-Q · filed 2013-11-05 | -$21.29M 10-Q · filed 2012-10-24 | -$18.23M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-06-30 | -$8.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$11.06M 10-Q · filed 2013-08-06 | -$13.37M 10-Q · filed 2012-07-25 | -$15.65M derived: sum of 3 quarters · filed 2014-02-13 | -$16.94M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-03-31 | -$2.49M 10-Q · filed 2013-05-03 | -$5.86M 10-Q · filed 2012-04-26 | -$7.09M derived: sum of 2 quarters · filed 2014-02-13 | -$8.38M derived: sum of 3 quarters · filed 2014-02-13 | -$8.63M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2011-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | -$5.88M derived: sum of 2 quarters · filed 2014-02-13 | -$6.13M derived: sum of 3 quarters · filed 2014-02-13 | -$6.71M 10-K · filed 2014-02-13 | -$10.37M 10-K · filed 2012-02-21 | |||
| 2011-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | -$1.54M derived: sum of 2 quarters · filed 2012-10-24 | -$2.12M 10-Q · filed 2012-10-24 | |||||
| 2011-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | -$832.00K 10-Q · filed 2012-07-25 | ||||||
| 2011-03-31 | -$582.00K 10-Q · filed 2012-04-26 | |||||||
| 2010-12-31 | -$4.04M 10-K · filed 2013-02-15 | -$3.17M 10-K · filed 2012-02-21 | ||||||
| 2009-12-31 | -$2.24M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |